Literature DB >> 12134136

The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides.

C Decristoforo1, S J Mather.   

Abstract

Because of the ideal properties of technetium-99m for imaging, more methods have been developed for labelling peptides and other biomolecules with this radionuclide that any other. While few detailed comparative studies have been performed, it has become apparent that the use of different labelling procedures can exert a profound effect on the pattern of biodistribution after intravenous administration of the radiotracer. The most significant influence of the labelling method is on the rate and route of excretion of the radionuclide. While some procedures tend to direct excretion towards the hepatobiliary route, others tend to favour renal clearance. Although the factors which exert this influence are still not fully understood, it is clear that the charge, lipophilicity and stability of the technetium-peptide complexes play major roles. A greater understanding of these factors will allow the development of improved radiotracers which demonstrate improved targeting potential as a result of lower uptake and consequent radiation dose by normal tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134136

Source DB:  PubMed          Journal:  Q J Nucl Med        ISSN: 1125-0135


  5 in total

Review 1.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

2.  SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.

Authors:  Lieven Huang; Lea Olive Tchouate Gainkam; Vicky Caveliers; Chris Vanhove; Marleen Keyaerts; Patrick De Baetselier; Axel Bossuyt; Hilde Revets; Tony Lahoutte
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

3.  99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.

Authors:  Torun Engfeldt; Thuy Tran; Anna Orlova; Charles Widström; Joachim Feldwisch; Lars Abrahmsen; Anders Wennborg; Amelie Eriksson Karlström; Vladimir Tolmachev
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06-13       Impact factor: 9.236

4.  Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3.

Authors:  Anzhelika Vorobyeva; Alexey Schulga; Elena Konovalova; Rezan Güler; John Löfblom; Mattias Sandström; Javad Garousi; Vladimir Chernov; Olga Bragina; Anna Orlova; Vladimir Tolmachev; Sergey M Deyev
Journal:  Sci Rep       Date:  2019-06-28       Impact factor: 4.379

5.  99mTc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging.

Authors:  Sajjad Ahmadpour; Zohreh Noaparast; Seyed Mohammad Abedi; Seyed Jalal Hosseinimehr
Journal:  J Biomed Sci       Date:  2018-02-19       Impact factor: 8.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.